← Leaderboards
Defne Bayik Watson
Cleveland Clinic Lerner Com-Cwru
$1,277,961
Attributed
$1,277,961
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $365K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,277,961 · 3
By mechanism
R00$943,450 · 1
K99$240,900 · 1
F32$93,611 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Michael A. Vogelbaum$845,078
- Jae U Jung$74,270,295
- Mina Kay Chung$7,078,575
- Feixiong Cheng$12,816,805
Others in their field
Other Emerging Leaders on “Monocyte”
- Markus Bosmann · Boston University Medical Campus$6,657,387
- Rebecca Terilli Veenhuis · Johns Hopkins University$6,518,477
- Maarten Hulsmans · Massachusetts General Hospital$5,811,869
- Eti Yoles · Immunobrain Checkpoint Inc.$5,749,685
- Daniel Lucas · Cincinnati Childrens Hosp Med Ctr$5,426,314
- Matthew Joel Feinstein · Northwestern University$5,201,748
Research focus
MonocyteTherapy ResistantIncidenceMalignant NeoplasmsPre-Clinical ModelSuccessImmunosuppressionImmunotherapyMalignant - DescriptorMalignant Neoplasm Of BrainMyeloid-Derived Suppressor CellsPeripheralPrimary Brain NeoplasmsResponseFemaleGranulocyteBehaviorGlioblastomaInsightMaleAnti-Tumor Immune ResponseCellsComplementTreatment Response
Grant awards (9)
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$248,998
R00 · FY2025 · CA · contact PI
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$248,995
R00 · FY2024 · CA · contact PI
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$116,034
R00 · FY2024 · CA · contact PI
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$248,997
R00 · FY2023 · CA · contact PI
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$80,426
R00 · FY2023 · CA · contact PI
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$120,450
K99 · FY2022 · CA · contact PI
Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma$120,450
K99 · FY2021 · CA · contact PI
Contribution of sex differences in glioblastoma immune suppression for improved immunotherapy response$29,865
F32 · FY2020 · CA · contact PI
Contribution of sex differences in glioblastoma immune suppression for improved immunotherapy response$63,746
F32 · FY2019 · CA · contact PI